angiotensin ii has been researched along with rhc 3659 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brunner, HR; Nussberger, J; Waeber, B | 1 |
| Brunner, HR; Burnier, M; Gavras, H; Kruithof, D; Porchet, M; Turini, GA; Vukovich, RA | 1 |
1 review(s) available for angiotensin ii and rhc 3659
| Article | Year |
|---|---|
The present molecules of converting enzyme inhibitors.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzazepines; Blood Pressure; Bridged Bicyclo Compounds; Captopril; Cilazapril; Cyclopentanes; Dipeptides; Enalapril; Humans; Indoles; Lisinopril; Perindopril; Pyridazines; Ramipril; Renin-Angiotensin System | 1985 |
1 other study(ies) available for angiotensin ii and rhc 3659
| Article | Year |
|---|---|
RHC 3659: a new orally active angiotensin converting enzyme inhibitor in normal volunteers.
Topics: Adult; Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Cyclopentanes; Dose-Response Relationship, Drug; Humans; Male; Renin; Time Factors | 1981 |